Novo Nordisk $NVO rises like a phoenix from the ashes!
Since the beginning of April, the stock has gained more than 41%, and after a multi‑year slump, better times may finally be on the horizon. However, competition from $LLY remains very tough. After all, it has performed much better in recent years, and that is reflected in its stock price.